Adverse reactions with Finacea® Foam vs foam vehicle
Adverse reactions occurring in ≥0.5% of subjects
|Adverse Reaction||Finacea® Foam, 15%
|Application site pain†||42 (6.2%)||10 (1.5%)|
|Application site pruritus||17 (2.5%)||2 (0.3%)|
|Application site dryness||5 (0.7%)||5 (0.7%)|
|Application site erythema||5 (0.7%)||6 (0.9%)|
Foam vehicle contained the same exact hydrophilic foam minus azelaic acid.
Application site pain is a term used to describe disagreeable skin sensations, including burning, stinging, paraesthesia, and tenderness.
Reference: Finacea® (azelaic acid) Foam, 15% [package insert]. Whippany, NJ: Bayer HealthCare Pharmaceuticals Inc; 2015.